Recommendations of the first Michigan conference on prostate cancer

By Porter A.T.   Zimmerman J.   Ruffin M.   Chernew M.   Callaghan C.   Davis R.   Lee F.   Montie J.   Swanson G.M.   Oesterling J.E.  

Urology, Vol. 48, Iss. 4, 1996-10 ,pp. : 519-534

Elsevier

Access to resources Recommend Favorite

Intracranial metastases as the first manifestation of prostate cancer

By Sutton M.A.   Watkins H.L.   Green L.K.   Kadmon D.  

Urology, Vol. 48, Iss. 5, 1996-11 ,pp. : 789-793

Elsevier

Access to resources Recommend Favorite

Metastatic Retroperitoneal and Mediastinal Fibrosis as First Sign of Recurrence of Breast Cancer

By Gogas John   Markopoulos Christos   Kouskos Efstratios   Gogas Helen   Kiriakou Vasiliki  

European Journal of Surgery, Vol. 167, Iss. 9, 2001-09 ,pp. : 715-718

Informa Healthcare

Access to resources Recommend Favorite

Atrasentan: The First Endothelin Receptor Antagonist for Hormone-Refractory Prostate Cancer

By Schulman C.  

European Urology Supplements, Vol. 2, Iss. 3, 2003-03 ,pp. : 20-27

Elsevier

Access to resources Recommend Favorite

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer

By Sartor O.   Dineen M.K.   Perez-Marreno R.   Chu F.M.   Carron G.J.   Tyler R.C.  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 319-323

Elsevier

Access to resources Recommend Favorite